Financière de Tubize S.A.
TUB
Rangering i aksjer
#2119
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Aksjekurs
$217.90
Sist synkronisert: 2026-10-20
Markedsverdi
$9.70B
Endring (1 dag)
5.57%
Endring (1 år)
-19.89%
Land
BE
Handel Financière de Tubize S.A. (TUB)
Kategori
Healthcare
Utbyttehistorikk for Financière de Tubize S.A. (TUB)
Financière de Tubize S.A. (aksjesymbol: TUB) har gitt totalt 26 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $13.63
Utbytteavkastning (TTM): 0.0065
Summen av alle utbytter (justert for aksjesplitt): $13.63
Utbytteavkastning (TTM): 0.0065
Utbyttebetalinger for Financière de Tubize S.A. (TUB) fra 2000 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $0.8945 | 0.00% |
| 2025 | $0.8945 | -7.78% |
| 2024 | $0.97 | 12.79% |
| 2023 | $0.86 | 14.67% |
| 2022 | $0.75 | 10.29% |
| 2021 | $0.68 | 9.68% |
| 2020 | $0.62 | 10.71% |
| 2019 | $0.56 | 3.70% |
| 2018 | $0.54 | 3.85% |
| 2017 | $0.52 | 4.00% |
| 2016 | $0.5 | 4.17% |
| 2015 | $0.48 | 0.00% |
| 2014 | $0.48 | 0.00% |
| 2013 | $0.48 | 0.00% |
| 2012 | $0.48 | 0.00% |
| 2011 | $0.48 | 0.00% |
| 2010 | $0.48 | 0.00% |
| 2009 | $0.48 | 1.42% |
| 2008 | $0.4733 | 2.16% |
| 2007 | $0.4633 | 2.21% |
| 2006 | $0.4533 | 3.02% |
| 2005 | $0.44 | 6.46% |
| 2004 | $0.4133 | 8.76% |
| 2003 | $0.38 | 21.29% |
| 2002 | $0.3133 | 23.69% |
| 2001 | $0.2533 | 35.67% |
| 2000 | $0.1867 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $0.8945 | 0.00% |
| 2025 | $0.8945 | -7.78% |
| 2024 | $0.97 | 12.79% |
| 2023 | $0.86 | 14.67% |
| 2022 | $0.75 | 10.29% |
| 2021 | $0.68 | 9.68% |
| 2020 | $0.62 | 10.71% |
| 2019 | $0.56 | 3.70% |
| 2018 | $0.54 | 3.85% |
| 2017 | $0.52 | 4.00% |
| 2016 | $0.5 | 4.17% |
| 2015 | $0.48 | 0.00% |
| 2014 | $0.48 | 0.00% |
| 2013 | $0.48 | 0.00% |
| 2012 | $0.48 | 0.00% |
| 2011 | $0.48 | 0.00% |
| 2010 | $0.48 | 0.00% |
| 2009 | $0.48 | 1.42% |
| 2008 | $0.4733 | 2.16% |
| 2007 | $0.4633 | 2.21% |
| 2006 | $0.4533 | 3.02% |
| 2005 | $0.44 | -46.78% |
| 2004 | $0.8267 | 8.78% |
| 2003 | $0.76 | 21.27% |
| 2002 | $0.6267 | 23.68% |
| 2001 | $0.5067 | 35.74% |
| 2000 | $0.3733 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
